All articles by Srivani Venna

  1. Epizyme’s Tazverik secures FDA approval to treat follicular lymphoma

    Epizyme has secured accelerated approval from the US Food and Drug Administration (FDA) for Tazverik to treat relapsed / refractory…
    Read More…

    19 Jun
  2. Alpine Immune and AbbVie sign $865m immunology deal

    Clinical-stage immunotherapy firm Alpine Immune Sciences and biopharmaceutical company AbbVie have signed an option and license agreement potentially worth $805m,…
    Read More…

    19 Jun
  3. Global clinical trials activity decreases 11.7% in Q1 2020

    Global clinical trials activity decreased by 11.7% in Q1 2020, when compared with the same quarter in 2019, according to…
    Read More…

    2 Jun
  4. Magenta, AVROBIO to evaluate antibody drug conjugate MGTA-117

    Magenta Therapeutics has signed an agreement with AVROBIO to evaluate the potential utility of its novel targeted antibody-drug conjugate (ADC)…
    Read More…

    7 May
  5. FDA approves AstraZeneca’s Farxiga to reduce risk of CV death

    The US Food and Drug Administration (FDA) has approved AstraZeneca’s Farxiga (dapagliflozin), the first SGLT2 inhibitor, to reduce the risk…
    Read More…

    7 May
  6. India’s CSIR proposes testing of sepsis drug as Covid-19 vaccine

    The Council of Scientific and Industrial Research (CSIR) in India has proposed the testing of sepsis treatment drug as a…
    Read More…

    7 May
  7. Asia-Pacific witnesses 5.4% increase in deal activity during week ended 19 April 2020

    Data and analytics company GlobalData has revealed that deal activity in the Asia-Pacific region has shown signs of revival during…
    Read More…

    21 Apr
  8. Global deal activity decreases 17.2% with 899 deals last week

    A total of 899 deals were announced globally during the week ended 12 April 2020, registering a 17.2% drop when…
    Read More…

    16 Apr
  9. Healthcare sector sees growth in deal activity for second consecutive week

    The deal activity in the global healthcare sector, including pharmaceuticals and medical equipment, has witnessed second consecutive week of growth,…
    Read More…

    9 Apr
  10. Covid-19 impact: Global VC funding activity continues to remain subdued

    The number of venture capital (VC) funding announced deals dropped by 22.5% during the week ended 29 March 2020 compared…
    Read More…

    3 Apr
Close
Close
Close

Go Top